Evofem Biosciences Inc. (EVFM) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-14
2:14 pm
Purchase
2023-12-3113GEVOFEM BIOSCIENCES INC PAR
EVFM
CVI Investments, Inc.102,799
0.900%
46,532increase
(+82.70%)
Filing
History
2023-02-14
11:24 am
Purchase
2022-12-3113GEVOFEM BIOSCIENCES INC
EVFM
CVI Investments, Inc.56,267
5.500%
50,934increase
(+955.07%)
Filing
History
2022-08-10
4:17 pm
Sale
2022-08-0913GEVOFEM BIOSCIENCES INC
EVFM
Cox Todd Stewart0
0.000%
-31,359decrease
(Position Closed)
Filing
History
2022-07-19
4:31 pm
Purchase
2022-06-3013GEVOFEM BIOSCIENCES INC
EVFM
Cox Todd Stewart31,359
9.290%
31,359increase
(New Position)
Filing
History
2022-02-14
3:30 pm
Sale
2021-12-3113GEVOFEM BIOSCIENCES INC
EVFM
CVI Investments, Inc.5,333
5.800%
-2,970decrease
(-35.77%)
Filing
History
2021-09-10
4:36 pm
Sale
2021-08-3113GEVOFEM BIOSCIENCES INC
EVFM
Morgan Stanley
MS
105
0.100%
-3,965decrease
(-97.42%)
Filing
History
2021-07-12
08:29 am
Sale
2021-06-3013GEVOFEM BIOSCIENCES INC
EVFM
BlackRock, Inc.
BLK
1,811
2.300%
-970decrease
(-34.88%)
Filing
History